Cytokines and growth factors involved in apoptosis and proliferation of vascular smooth muscle cells

International Immunopharmacology

Volumn 5, Issue 10, 2005, Pages 1487-1506

  Rakesh, Kriti ^a   Agrawal, Devendra K ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Atherosclerosis; Cytokines; Growth factors; Plaque stability; Vascular smooth muscle cells

Indexed keywords

ANTIOXIDANT; ANTISENSE OLIGONUCLEOTIDE; AUTACOID; BASIC FIBROBLAST GROWTH FACTOR; CASPASE 3; CD40 LIGAND; CHEMOKINE; CYTOKINE; EPIDERMAL GROWTH FACTOR; GLUTATHIONE; GROWTH FACTOR; INTERLEUKIN 1BETA; NICOTINE; OXIDIZED LOW DENSITY LIPOPROTEIN; PLATELET DERIVED GROWTH FACTOR; PROTEIN BCL 2; PROTEIN P53; SOMATOMEDIN; SUPEROXIDE DISMUTASE; VASCULOTROPIN; VIRUS T ANTIGEN; VITAMIN;

APOPTOSIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL ACTIVATION; CELL INTERACTION; CELL PROLIFERATION; CELL SURVIVAL; CHLAMYDOPHILA PNEUMONIAE; CYTOKINE RELEASE; DISEASE COURSE; DNA POLYMORPHISM; ENDOTHELIUM INJURY; GENE CONTROL; HEART INFARCTION; HUMAN; INFLAMMATORY CELL; LIPID STORAGE; MITOCHONDRION; MOLECULAR MECHANICS; MOLECULAR STABILITY; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; SHEAR STRESS; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; THROMBOSIS; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOPTOSIS; ARTERIOSCLEROSIS; CELL PROLIFERATION; CYTOKINES; GROWTH SUBSTANCES; HUMANS; MUSCLE, SMOOTH, VASCULAR;

EID: 22044442434     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2005.05.003     Document Type: Review

References (201)

1. J. Zhou, M. Chew, H.B. Ravn, and E. Falk Plaque pathology and coronary thrombosis in the pathogenesis of acute coronary syndromes Scand J Clin Lab Invest, Suppl 230 1999 3 11
2. M.J. Davies, P.D. Richardson, N. Woolf, D.R. Katz, and J. Mann Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content Br Heart J 69 1993 377 381
3. P.R. Moreno, E. Falk, I.F. Palacios, J.B. Newell, V. Fuster, and J.T. Fallon Macrophage infiltration in acute coronary syndromes: implications for plaque rupture Circulation 90 1994 775 778
4. G. Bauriedel, R. Hutter, U. Welsch, R. Bach, H. Sievert, and B. Luderitz Role of smooth muscle cell death in advanced coronary primary lesions: implications for plaque instability Cardiovasc Res 41 1999 480 488
5. E.P. Moiseeva Adhesion receptors of vascular smooth muscle cells and their functions Cardiovasc Res 52 2001 372 386
6. E.W. Greeno, R.R. Bach, and C.F. Moldow Apoptosis is associated with increased cell surface tissue factor procoagulant activity Lab Invest 75 1996 281 289
7. L.H. Arroyo, and R.T. Lee Mechanism of plaque rupture: mechanical and biologic interactions Cardiovasc Res 41 1999 369 375
8. A.C. Van der Wal, and A.E. Becker Atherosclerotic plaque rupture-pathologic basis of plaque stability and instability Cardiovasc Res 41 1999 334 344
9. Z.S. Gallis, G.K. Sukhova, M.W. Lark, and P. Libby Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques J Clin Invest 94 1994 2493 2503
10. A.C. Newby, and A.B. Zaltsman Fibrous cap formation or destruction-the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation Cardiovasc Res 41 1999 345 360
11. Alan Daugherty, and Debra L. Rateri T lymphocytes in atherosclerosis. The yin-yang of Th1 and Th2 influence on lesion formation Circ Res 90 2002 1039
12. M.D. Rekhter Collagen synthesis in atherosclerosis: too much and not enough Cardiovasc Res 41 1999 376 384
13. A.H. Ang, G. Tachas, J.H. Campbell, J.F. Bateman, and G.R. Campbell Collagen synthesis by cultured rabbit aortic smooth-muscle cells. Alteration with phenotype Biochem J 265 1999 461 469
14. M.D. Rekhter, and D. Gordon Cell proliferation and collagen synthesis are two independent events in human atherosclerotic plaques J Vasc Res 31 1994 280 286
15. M.M. Kockx, G.R. De Meyer, J. Muhring, W. Jacob, H. Bult, and A.G. Herman Apoptosis and related proteins in different stages of human atherosclerotic plaques Circulation 97 1998 2307 2315
16. M.M. Kockx, G.R.Y. De Meyer, H. Bortier, N. de Meyere, J. Muhring, and A. Bakker Luminal foam cell accumulation is associated with smooth muscle cell death in the intimal thickening of human saphenous vein grafts Circulation 94 1996 1255 1262
17. M.M. Kockx, J. Muhring, H. Bortier, G.R.Y. De Meyer, and W. Jacob Biotin or digoxigenin conjugated nucleotides bind to matrix vesicles in atherosclerotic plaques Am J Pathol 148 1996 1771 1777
18. P.D. Flynn, C.D. Byrne, T.P. Baglin, P.L. Weissberg, and M.R. Bennett Thrombin generation by apoptotic vascular smooth muscle cells Blood 89 1997 4378 4384
19. M.C. Stuart, J.G. Damoiseaux, P.M. Frederik, J.W. Arends, and C.P. Reutelingsperger Surface exposure of phosphatidylserine during apoptosis of rat thymocytes precedes nuclear changes Eur J Cell Biol 76 1998 77 83
20. N. Platt, R.P. Da Silva, and S. Gordon Recognizing death: the phagocytosis of apoptotic cells Trends Cell Biol 8 1998 365 372
21. J. Savill Recognition and phagocytosis of cells undergoing apoptosis Br Med Bull 53 1997 491 508
22. G.R. Sambrano, S. Parthasarathy, and D. Steinberg Recognition of oxidatively damaged erythrocytes by a macrophage receptor with specificity for oxidized low density lipoprotein Proc Natl Acad Sci U S A 91 1994 3265 3269
23. G.R. Sambrano, and D. Steinberg Recognition of oxidative and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine Proc Natl Acad Sci U S A 92 1995 1396 1400
24. D. Steinberg, and A. Lewis Conner Memorial Lecture: oxidative modification of LDL and atherogenesis Circulation 95 1997 1062 1071
25. T.M. Burke, and P.A. Sandstrom Oxidative stress as a mediator of apoptosis Immunol Today 15 1994 7 10
26. M. Krieger The other side of scavenger receptors: pattern recognition for host defense Curr Opin Lipidol 8 1997 275 280
27. M.D. Rekhter Collagen synthesis in atherosclerosis: too much and not enough Cardiovasc Res 41 1999 376 384
28. U.E. Knies, H.A. Behrensdorf, C.A. Mitchell, U. Deutsch, W. Risau, and H.C. Drexler Regulation of endothelial monocyte-activating polypeptide II release by apoptosis Proc Natl Acad Sci U S A 95 1998 12322 12327
29. J. Kao, K. Houck, Y. Fan, I. Haehnel, S.K. Libutti, and M.L. Kayton Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II J Biol Chem 269 1994 25106 25119
30. T. Bombeli, A. Karsan, J.F. Tait, and J.M. Harlan Apoptotic vascular endothelial cells become procoagulant Blood 89 1997 2429 2442
31. E.W. Greeno, R.R. Bach, and C.F. Moldow Apoptosis is associated with increased cell surface tissue factor procoagulant activity Lab Invest 75 1996 281 289
32. V. Toschi, R. Gallo, M. Lettino, J.T. Fallon, S.D. Gertz, and A. Fernandez-Ortiz Tissue factor modulates thrombogenicity of human atherosclerotic plaques Circulation 95 1997 594 599
33. Z. Mallat, B. Hugel, J. Ohan, G. Leseche, J.M. Freyssinet, and A. Tedgui Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity Circulation 99 1999 348 353
34. Mark M. Kockx, and Michiel W.M. Knaapen The role of apoptosis in vascular disease J Pathol 190 2000 267 280
35. P. Libby, Y.J. Geng, M. Aikawa, U. Schoenbeck, F. Mach, and S.K. Clinton Macrophages and atherosclerotic plaque stability Curr Opin Lipidol 7 1996 330 335
36. P. Libby, Y.J. Geng, G.K. Sukhova, D.I. Simon, and R.T. Lee Molecular determinants of atherosclerotic plaque vulnerability Ann NY Acad Sci 811 1997 134 145
37. V. Fuster, B. Stein, J.A. Ambrose, L. Badimon, J.J. Badimon, and J.H. Chesebro Atherosclerotic plaque rupture and thrombosis: evolving concepts Circulation 82 suppl II 1990 II-47 II-59
38. M.J. Davies, N. Woolf, P. Rowles, and P.D. Richardson Lipid and cellular constituents of unstable human aortic plaques Basic Res Cardiol 89 1994 33 39
39. J. Golledge, R.M. Greenhalgh, and A.H. Davies The symptomatic carotid plaque Stroke 31 2000 774 781
40. P.D. Flynn, C.D. Byrne, T.P. Baglin, P.L. Weissberg, and M.R. Bennett Thrombin generation by apoptotic vascular smooth muscle cells Blood 89 1997 4378 4384
41. E.W. Greeno, R.R. Bach, and C.F. Moldow Apoptosis is associated with increased cell surface tissue factor procoagulant activity Lab Invest 75 1996 281 289
42. Z. Wang, M.R. Castresana, and W.H. Newman NF-kappaB is required for TNF-alpha-directed smooth muscle cell migration FEBS Lett 508 2001 360 364
43. C. Viedt, J. Vogel, T. Athanasiou, W. Shen, S.R. Orth, and W. Kubler Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1 Arterioscler Thromb Vasc Biol 22 2002 914 920
44. J. Zhou, M. Chew, H.B. Ravn, and E. Falk Plaque pathology and coronary thrombosis in the pathogenesis of acute coronary syndromes Scand J Clin Lab Invest, Suppl 230 1999 3 11
45. M.J. Davies, P.D. Richardson, N. Woolf, D.R. Katz, and J. Mann Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content Br Heart J 69 1993 377 381
46. P.R. Moreno, E. Falk, I.F. Palacios, J.B. Newell, V. Fuster, and J.T. Fallon Macrophage infiltration in acute coronary syndromes: implications for plaque rupture Circulation 90 1994 775 778
47. M. Harada-Shiba, M. Kinoshita, H. Kamido, and K. Shimokado Oxidized low density lipoprotein induces apoptosis in cultured human umbilical vein endothelial cells by common and unique mechanisms J Biol Chem 273 1998 9681 9687
48. G. Bauriedel, R. Hutter, U. Welsch, R. Bach, H. Sievert, and B. Luderitz Role of smooth muscle cell death in advanced coronary primary lesions: implications for plaque instability Cardiovasc Res 41 1999 480 488
49. T. Biwa, H. Hakamata, M. Sakai, A. Miyazaki, H. Suzuki, and T. Kodama Induction of murine macrophage growth by oxidized low-density lipoprotein is mediated by granulocyte macrophage colony-stimulating factor J Biol Chem 273 1998 28305 28313
50. T. Biwa, M. Sakai, T. Matsumura, S. Kobori, K. Kaneko, and A. Miyazaki Sites of action of protein kinase C and phosphatidylinositol 3-kinase are distinct in oxidized low-density lipoprotein-induced macrophage proliferation J Biol Chem 275 2000 5810 5816
51. J. Reibman, A.T. Talbot, Y. Hsu, G. Ou, J. Jover, and D. Nilsen Regulation of expression of granulocyte-macrophage colony-stimulating factor in human bronchial epithelial cells: roles of protein kinase C and mitogen-activated protein kinases J Immunol 165 2000 1618 1625
52. M. Egerton, D.R. Fitzpatrick, A.D. Catling, and A. Kelso Differential activation of T cell cytokine production by the extracellular signal-regulated kinase (ERK) signaling pathway Eur J Immunol 26 1996 2279 2285
53. Takafumi Senokuchi Extracellular signal-regulated kinase and p38 mitogen-activated protein kinase mediate macrophage proliferation induced by oxidized low-density lipoprotein Atherosclerosis 176 2004 233 245
54. Alan Daugherty, and Debra L. Rateri T lymphocytes in atherosclerosis. The yin-yang of Th1 and Th2 influence on lesion formation Circ Res 90 2002 1039
55. X.H. Zhou, G. Paulsson, S. Stemme, and G.K. Hansson Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice J Clin Invest 101 1998 1717 1725
56. S.A. Huber, P. Sakkinen, C. David, M.K. Newell, and R.P. Tracy T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia Circulation 103 2001 2610 2616
57. S. Gupta, A.M. Pablo, X.C. Jiang, N. Wang, A.R. Tall, and C. Schindler IFN-γ potentiates atherosclerosis in apoE knock-out mice J Clin Invest 99 1997 2752 2761
58. S.C. Whitman, P. Ravisankar, and A. Daugherty Interferon-γ deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-/-mice J Interferon Cytokine Res 22 2002 661 670
59. S.C. Whitman, P. Ravisankar, H. Elam, and A. Daugherty Exogenous interferon-γ enhances atherosclerosis in apolipoprotein E-/-mice Am J Pathol 157 2000 1819 1824
60. T.S. Lee, H.C. Yen, C.C. Pan, and L.Y. Chau The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice Arterioscler Thromb Vasc Biol 19 1999 734 742
61. -/-mice through release of interferon-γ Circ Res 90 2002 e34 e38
62. K. Uyemura, L.L. Demer, S.C. Castle, D. Jullien, J.A. Berliner, and M.K. Gately Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis J Clin Invest 97 1996 2130 2138
63. K.W. Moore, R. de Waal Malefyt, R.L. Coffman, and A. O'Garra Interleukin-10 and the interleukin-10 receptor Annu Rev Immunol 19 2001 683 765
64. J.S. Silvestre, Z. Mallat, R. Tamarat, M. Duriez, A. Tedgui, and B.I. Levy Regulation of matrix metalloproteinase activity in ischemic tissue by interleukin-10: role in ischemia-induced angiogenesis Circ Res 89 2001 259 264
65. F.Q. Cunha, S. Moncada, and F.Y. Liew Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-γ in murine macrophages Biochem Biophys Res Commun 182 1992 1155 1159
66. O. Pradier, C. Gerard, A. Delvaux, M. Lybin, D. Abramowicz, and P. Capel Interleukin-10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharide Eur J Immunol 23 1993 2700 2703
67. Y.J. Geng, T. Azuma, J.X. Tang, J.H. Hartwig, M. Muszynski, and Q. Wu Caspase-3-induced gelsolin fragmentation contributes to actin cytoskeletal collapse, nucleolysis, and apoptosis of vascular smooth muscle cells exposed to proinflammatory cytokines Eur J Cell Biol 77 1998 294 302
68. A. Iwasaki, and R. Medzhitov Toll-like receptor control of the adaptive immune responses Nat Immunol 5 10 2004 (Oct) 987 995
69. M. Weis, C.L. Schlichting, E.G. Engleman, and J.P. Cooke Endothelial determinants of dendritic cell adhesion and migration: new implications for vascular diseases Arterioscler Thromb Vasc Biol 22 2002 1817 1823
70. A. Yilmaz, M. Lochno, F. Traeg, I. Cicha, C. Reiss, and C. Stumpf Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques Atherosclerosis 176 2004 101 110
71. W. Cao, Y.V. Bobryshev, R.S. Lord, R.E. Oakley, S.H. Lee, and J. Lu Dendritic cells in the arterial wall express C1q: potential significance in atherogenesis Cardiovasc Res 60 2003 175 186
72. L. Perrin-Cocon, F. Coutant, S. Agaugue, S. Deforges, P. Andre, and V. Lotteau Oxidized low-density lipoprotein promotes mature dendritic cell transition from differentiating monocyte J Immunol 167 2001 3785 3791
73. C.J. Alderman, P.R. Bunyard, B.M. Chain, J.C. Foreman, D.S. Leake, and D.R. Katz Effects of oxidised low density lipoprotein on dendritic cells: a possible immunoregulatory component of the atherogenic micro-environment? Cardiovasc Res 55 2002 806 819
74. A. Aicher, C. Heeschen, M. Mohaupt, J.P. Cooke, A.M. Zeiher, and S. Dimmeler Nicotine strongly activates dendritic cell-mediated adaptive immunity: potential role for progression of atherosclerotic lesions Circulation 107 2003 604 611
75. J.H. von der Thusen, J. Kuiper, T.J. van Berkel, and E.A. Biessen Interleukins in atherosclerosis: molecular pathways and therapeutic potential Pharmacol Rev 55 2003 133 166
76. Z.S. Galis, M. Muszynski, G.K. Sukhova, E. Simon-Morrissey, and P. Libby Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions Ann NY Acad Sci 1995 748501 748507
77. G.K. Hansson, S. Stemme, Y.J. Geng, and J. Holm Can immunocompetent cells and their cytokines play a role in atherogenesis? Nouv Rev Fr Hematol 34 1992 S43 S46
78. N. Auge, A. Negre-Salvayre, R. Salvayre, and T. Levade Sphingomyelin metabolites in vascular cell signaling and atherogenesis Prog Lipid Res 39 2000 207 229
79. Y.J. Geng, M. Almqvist, and G.K. Hansson cDNA cloning and expression of inducible nitric oxide synthase from rat vascular smooth muscle cells Biochim Biophys Acta 1218 1994 421 424
80. Y.J. Geng, A.S. Petersson, A. Wennmalm, and G.K. Hansson Cytokine-induced expression of nitric oxide synthase results in nitrosylation of heme and nonheme iron proteins in vascular smooth muscle cells Exp Cell Res 214 1994 418 428
81. Y.J. Geng, G.K. Hansson, and E. Holme Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells Circ Res 71 1992 1268 1276
82. S. Chatterjee Sphingolipids in atherosclerosis and vascular biology Arterioscler Thromb Vasc Biol 18 1998 1523 1533
83. Y.J. Geng, K. Hellstrand, A. Wennmalm, and G.K. Hansson Apoptotic death of human leukemic cells induced by vascular cells expressing nitric oxide synthase in response to gamma-interferon and tumor necrosis factor-alpha Cancer Res 56 1996 866 874
84. N. Auge, A. Negre-Salvayre, R. Salvayre, and T. Levade Sphingomyelin metabolites in vascular cell signaling and atherogenesis Prog Lipid Res 39 2000 207 229
85. S. Chatterjee Sphingolipids in atherosclerosis and vascular biology Arterioscler Thromb Vasc Biol 18 1998 1523 1533
86. G.K. Hansson, Y.J. Geng, J. Holm, P. Hardhammar, A. Wennmalm, and E. Jennische Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury J Exp Med 180 1994 733 738
87. Y. Geng, G.K. Hansson, and E. Holme Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells Circ Res 71 1992 1268 1276
88. Y.J. Geng, M. Almqvist, and G.K. Hansson cDNA cloning and expression of inducible nitric oxide synthase from rat vascular smooth muscle cells Biochim Biophys Acta 1218 1994 421 424
89. Y.J. Geng, A.S. Petersson, A. Wennmalm, and G.K. Hansson Cytokine-induced expression of nitric oxide synthase results in nitrosylation of heme and nonheme iron proteins in vascular smooth muscle cells Exp Cell Res 214 1994 418 428
90. Y.J. Geng, K. Hellstrand, A. Wennmalm, and G.K. Hansson Apoptotic death of human leukemic cells induced by vascular cells expressing nitric oxide synthase in response to gamma-interferon and tumor necrosis factor-alpha Cancer Res 56 1996 866 874
91. Y.J. Geng, Q. Wu, M. Muszynski, G.K. Hansson, and P. Libby Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta Arterioscler Thromb Vasc Biol 16 1996 19 27
92. M.D. Rekhter Collagen synthesis in atherosclerosis: too much and not enough Cardiovasc Res 41 1999 376 384
93. K. Fukuo, T. Nakahashi, S. Nomura, S. Hata, T. Suhara, and M. Shimizu Possible participation of Fas-mediated apoptosis in the mechanism of atherosclerosis Gerontology 1 1997 35 42
94. Y.J. Geng, L.E. Henderson, E.B. Levesque, M. Muszynski, and P. Libby Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells Arterioscler Thromb Vasc Biol 17 1997 2200 2208
95. K. Walsh, and M. Sata Is extravasation a Fas-regulated process? Mol Med Today 5 1999 61 67
96. D.B. Schneider, G. Vassalli, S. Wen, R.M. Driscoll, A.B. Sassani, and M.B. DeYoung Expression of Fas ligand in arteries of hypercholesterolemic rabbits accelerates atherosclerotic lesion formation Arterioscler Thromb Vasc Biol 20 2000 298 308
97. Y.J. Geng, and P. Libby Evidence for apoptosis in advanced human atheroma. Co-localization with interleukin-1 beta-converting enzyme Am J Pathol 147 1995 251 266
98. W. Cai, B. Devaux, W. Schaper, and J. Schaper The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions Atherosclerosis 131 1997 177 186
99. S. Bjorkerud, and B. Bjorkerud Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability Am J Pathol 149 1996 367 380
100. T. Saitoh, H. Kishida, Y. Tsukada, Y. Fukuma, J. Sano, and M. Yasutake Clinical significance of increased plasma concentration of macrophage colony stimulating factor in patients with angina pectoris J Am Coll Cardiol 35 2000 655 665
101. Puvi N. Seshiah, Dean J. Kereiakes, Sanjay S. Vasudevan, Neuza Lopes, Baogen Y. Su, and Nicholas A. Flavahan Activated monocytes induce smooth muscle cell death Circulation 105 2002 174
102. K. Hishikawa, B.S. Oemar, F.C. Tanner, T. Nakaki, T. Fujii, and T.F. Luscher Overexpression of connective tissue growth factor gene induces apoptosis in human aortic smooth muscle cells Circulation 100 1999 2108 2112
103. D. Fukui, S. Miyagawa, J. Soeda, K. Tanaka, H. Urayama, and S. Kawasaki Overexpression of transforming growth factor beta1 in smooth muscle cells of human abdominal aortic aneurysm Eur J Vasc Endovasc Surg 25 2003 540 545
104. F. Mach, U. Schonbeck, G.K. Sukhova, T. Bourcier, J.Y. Bonnefoy, and J.Y. Pober Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis Proc Natl Acad Sci U S A 94 1997 1931 1936
105. U. Schonbeck, F. Mach, G.K. Sukhova, M. Herman, P. Graber, and M.R. Kehry CD40 ligation induces tissue factor expression in human vascular smooth muscle cells Am J Pathol 156 2000 7 14
106. U. Schonbeck, F. Mach, J.Y. Bonnefoy, H. Loppnow, H.D. Flad, and P. Libby Ligation of CD40 activates interleukin 1beta-converting enzyme (caspase-1) activity in vascular smooth muscle cells and endothelial cells and promotes elaboration of active interleukin 1beta J Biol Chem 272 1997 19569 19574
107. F. Mach, U. Schonbeck, R.P. Fabunmi, C. Murphy, E. Atkinson, and J.Y. Bonnefoy T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: implications for tubule formation Am J Pathol 154 1999 229 238
108. F. Mach, U. Schonbeck, J.Y. Bonnefoy, J.S. Pober, and P. Libby Activation of monocyte/macrophage functions related to acute atheroma complications by ligation of CD40: induction of collagenase, stromelysin and tissue factor Circulation 96 1997 396 399
109. A.E. Becker, O.J. de Boer, and A.C. van Der Wal The role of inflammation and infection in coronary artery disease Annu Rev Med 52 2001 289 297
110. P. Libby, D. Egan, and S. Skarlatos Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research Circulation 96 1997 4095 4103
111. S. O'Connor, C. Taylor, L.A. Campbell, S. Epstein, and P. Libby Potential infectious etiologies of atherosclerosis: a multifactorial perspective Emerg Infect Dis 7 2001 780 788
112. Y. Wang, and P.T. Kovanen Heparin proteoglycans released from rat serosal mast cells inhibit proliferation of rat aortic smooth muscle cells in culture Circ Res 84 1998 74 83
113. C.C. Kuo, A.M. Gown, E.P. Benditt, and J.T. Grayston Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain Arterioscler Thromb 13 1993 1501 1504
114. C.C. Kuo, A. Shor, L.A. Campbell, H. Kukushi, D.L. Patton, and J.T. Grayston Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries J Infect Dis 167 1993 841 849
115. C.A. Gaydos, J.T. Summersgill, N.N. Sahney, J.A. Ramirez, and T.C. Quinn Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells Infect Immun 64 1996 1614 1620
116. K.L. Godzik, E.R. O'Brien, S.K. Wang, and C.C. Kuo In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae J Clin Microbiol 33 1995 2411 2414
117. W.L. Beatty, G.I. Byrne, and R.P. Morrison Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro Proc Natl Acad Sci U S A 90 1993 3998 4002
118. A.M. Coles, D.J. Reynolds, A. Harper, A. Devitt, and J.H. Pearce Low-nutrient induction of abnormal chlamydial development: a novel component of chlamydial pathogenesis? FEMS Microbiol Lett 106 1993 193 200
119. A. Matsumoto, and G.P. Manire Electron microscopic observations on the effects of penicillin on the morphology of Chlamydia psittaci J Bacteriol 101 1970 278 285
120. G.I. Byrne, L.K. Lehmann, and G.J. Landry Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells Infect Immun 53 1986 347 351
121. L.G. Pantoja, R.D. Miller, J.A. Ramirez, R.E. Molestina, and J.T. Summersgill Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2, 3-dioxygenase activity Infect Immun 68 2000 6478 6481
122. L.G. Pantoja, R.D. Miller, J.A. Ramirez, R.E. Molestina, and J.T. Summersgill Characterization of Chlamydia pneumoniae persistence in HEp-2 cells treated with gamma interferon Infect Immun 69 2001 7927 7932
123. Jürgen Rödel, Sentayehu Assefa, Dirk Prochnau, Marcus Woytas, Matthias Hartmann, and Annemarie Groh Interferon-β induction by Chlamydia pneumoniae in human smooth muscle cells FEMS Immunol Med Microbiol 32 1 2001 (December) 9 15
124. Y. Momiyama, R. Hirano, H. Taniguchi, H. Nakamura, and F. Ohsuzu Effects of interleukin-1 gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumoniae infection J Am Coll Cardiol 38 2001 712 717
125. J. Oyama, H. Shimokawa, S. Morita, H. Yasui, and A. Takeshita Elevated interleukin-1beta in pericardial fluid of patients with ischemic heart disease Coron Artery Dis 12 2001 567 571
126. M. Kaartinen, A. Penttilä, and P.T. Kovanen Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture Circulation 90 1994 1669 1678
127. P.T. Kovanen, M. Kaartinen, and T. Paavonen Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction Circulation 92 1995 1084 1088
128. M. Jeziorska, C. McCollum, and D.E. Woolley Mast cell distribution, activation, and phenotype in atherosclerotic lesions of human carotid arteries J Pathol 182 1997 115 122
129. L.B. Schwartz, and K.F. Austen Structure and function of the chemical mediators of mast cells K. Ishizaka Mast cell activation and mediator release 1984 S Karger Basel, Switzerland 271 321
130. Y. Wang, and P.T. Kovanen Heparin proteoglycans released from rat serosal mast cells inhibit proliferation of rat aortic smooth muscle cells in culture Circ Res 84 1998 74 83
131. Markus Leskinen, Yenfeng Wang, Dariusz Leszczynski, Ken A. Lindstedt, and Petri T. Kovanen Mast cell chymase induces apoptosis of vascular smooth muscle cells Arterioscler Thromb Vasc Biol 21 2001 516
132. R.E. Gerszten, E.A. Garcia-Zepeda, Y.C. Lim, M. Yoshida, H.A. Ding, and M.A. Gimbrone Jr. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions Nature 398 1999 718 723
133. C.G. Larsen, A.O. Anderson, E. Appella, J.J. Oppenheim, and K. Matsushima The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes Science 243 1989 1464 1466
134. M. Takahashi, U. Ikeda, T. Kasahara, S. Kitagawa, Y. Takahashi, and K. Shimada Activation of human monocytes for enhanced production of interleukin 8 during transendothelial migration in vitro J Clin Immunol 17 1997 53 62
135. T.L. Yue, X. Wang, C.P. Sung, B. Olson, P.J. McKenna, and J.L. Gu Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells Circ Res 75 1994 1 7
136. F.J. Schaub, D.K. Han, W. Conrad Liles, L.A. Adams, S.A. Coats, and R.K. Ramachandran Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells Nat Med 6 2000 790 796
137. J.M. Wang, A. Sica, G. Peri, S. Walter, I.M. Padura, and P. Libby Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells Arterioscler Thromb 11 1991 1166 1174
138. Takayuki Ito, Uichi Ikeda, Keiji Yamamoto, and Kazuyuki Shimada Regulation of interleukin-8 expression by HMG-CoA reductase inhibitors in human vascular smooth muscle cells Atherosclerosis 165 2002 51 55
139. Z. Mallat, A. Corbaz, A. Scoazec, P. Graber, S. Alouani, and B. Esposito IL-18/IL-18BP signaling modulates atherosclerotic lesion development and stability Circ Res 89 2001 e41
140. C.A. Dinarello IL-18: a T-H1-inducing, proinflammatory cytokine and new member of the IL-1 family J Allergy Clin Immunol 103 1999 11 24
141. O. Tricot, Z. Mallat, C. Heymes, J. Belmin, G. Leseche, and A. Tedgui Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques Circulation 101 2000 2450 2453
142. O. Katoh, H. Tauchi, K. Kawaishi, A. Kimura, and Y. Satow Expression of the vascular endothelial growth factor (VEGF) effect of VEGF on apoptotic cell death caused by ionizing radiation Cancer Res 55 1995 5687 5692
143. K. Heermeier, R. Schneider, A. Heinloth, C. Wanner, S. Dimmeler, and J. Galle Oxidative stress mediates apoptosis induced by oxidized low-density lipoprotein and oxidized lipoprotein(a) Kidney Int 56 1999 1310 1312
144. R.C. Siow, H. Sato, D.S. Leake, T. Ishii, S. Bannai, and G.E. Mann Induction of antioxidant stress proteins in vascular endothelial and smooth muscle cells: protective action of vitamin C against atherogenic lipoproteins Free Radic Res 31 1999 309 318
145. T.A. McCaffrey, B. Du, C. Fu, P.J. Bray, T.A. Sanborn, and E. Deutsch The expression of TGF-beta receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance J Mol Cell Cardiol 31 1999 1627 1642
146. M.R. Bennett, G.I. Evan, and S.M. Schwartz Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques J Clin Invest 95 1995 2266 2274
147. O. Katoh, H. Tauchi, K. Kawaishi, A. Kimura, and Y. Satow Expression of the vascular endothelial growth factor (VEGF) effect of VEGF on apoptotic cell death caused by ionizing radiation Cancer Res 55 1995 5687 5692
148. J.C. Fox, and J.R. Shanley Antisense inhibition of basic fibroblast growth factor induces apoptosis in vascular smooth muscle cells J Biol Chem 271 1996 12578 12584
149. J. Golledge, R.M. Greenhalgh, and A.H. Davies The symptomatic carotid plaque Stroke 31 2000 774 781
150. P.D. Flynn, C.D. Byrne, T.P. Baglin, P.L. Weissberg, and M.R. Bennett Thrombin generation by apoptotic vascular smooth muscle cells Blood 89 1997 4378 4384
151. P. Libby, Y.J. Geng, M. Aikawa, U. Schoenbeck, F. Mach, and S.K. Clinton Macrophages and atherosclerotic plaque stability Curr Opin Lipidol 7 1996 330 335
152. S. Araki, Y. Simada, K. Kaji, and H. Hayashi Role of protein kinase C in the inhibition by fibroblast growth factor of apoptosis in serum-depleted endothelial cells Biochem Biophys Res Commun 172 1990 1081 1085
153. F.A. Haimovitz, N. Balaban, M. McLoughlin, D. Ehleiter, J. Michaeli, and I. Vlodavsky Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis Cancer Res 54 1994 2591 2597
154. G. Lizard, S. Gueldry, O. Sordet, S. Monier, A. Athias, and C. Miguet Glutathione is implied in the control of 7-ketocholesterol-induced apoptosis, which is associated with radical oxygen species production FASEB J 12 1998 1651 1663
155. J.I. Jones, and D.R. Clemmons Insulin-like growth factors and their binding proteins: biological actions Endocr Rev 16 1995 3 34
156. P. Delafontaine Insulin-like growth factor 1 and its binding proteins in the cardiovascular system Cardiovasc Res 30 1995 825 834
157. A.C. Newby, and A.B. Zaltsman Fibrous cap formation or destruction: the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation Cardiovasc Res 41 1999 345 360
158. R.T. Lee, and P. Libby The unstable atheroma Arterioscler Thromb Vasc Biol 17 1997 1859 1867
159. J.A. Tyler Insulin-like growth factor 1 can decrease degradation and promote synthesis of proteoglycan in cartilage exposed to cytokines Biochem J 260 1989 543 548
160. J.L. Bird, and J.A. Tyler Tumour necrosis factor-α interferon γ and dexamethasone regulate IGF-1 maintained collagen production in cultured human fibroblasts J Endocrinol 147 1995 167 176
161. Y. Wu, M. Tewari, S. Cui, and R. Rubin Activation of the insulin-like growth factor-1 receptor inhibits tumor necrosis factor-induced cell death J Cell Physiol 168 1996 499 509
162. A. Juul, T. Scheike, M. Davidsen, J. Gyllenborg, and T. Jorgensen Low serum insulin like growth factor 1 is associated with risk of ischemic heart disease Circulation 106 2002 939 944
163. A. Anwar, A.A. Zahid, K.J. Scheidegger, M. Brink, and P. Delafontaine Tumor necrosis factor-α regulates insulin-like growth factor-1 and insulin-like growth factor binding protein-3 expression in vascular smooth muscle Circulation 105 2002 1220 1226
164. V.A. Patel, Q.J. Zhang, K. Siddle, M.A. Soos, M. Goddard, and P.L. Weissberg Defect in insulin-like growth factor-1 survival mechanism in atherosclerotic plaque-derived vascular smooth muscle cells is mediated by reduced surface binding and signaling Circ Res 88 2001 895 902
165. J.I. Jones, and D.R. Clemmons Insulin like growth factor and their binding proteins: biologic actions Endocr Rev 16 1995 3 34
166. C. Camacho-Hubner, W.H. Busby, R.H. McCusker, G. Wright, and D.R. Clemmons Identification of the forms of insulin-like growth factor binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion J Biol Chem 267 1992 11949 11956
167. Y. Imai, A. Moralez, U. Andag, J.B. Clarke, W.H. Busby, and D.R. Clemmons Substitutions for hydrophobic amino acids in the N terminal domain of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions J Biol Chem 275 2000 18188 18194
168. J. Fan, M.M. Woinar, M. Theodorakis, and C.H. Lang Regulation of
169. M.M. Kockx, G.R.Y. De Meyer, J. Muhring, W. Jacob, H. Bult, and A.G. Herman Apoptosis and related proteins in different stages of human atherosclerotic plaques Circulation 97 1998 2307 2315
170. J.H. von der Thusen, J. Kuiper, T.J. van Berkel, and E.A. Biessen Interleukins in atherosclerosis: molecular pathways and therapeutic potential Pharmacol Rev 55 2003 133 166
171. Y.J. Geng Regulation of programmed cell death or apoptosis in atherosclerosis Heart Vessels 1997 76 80 [Suppl]
172. M.M. Kockx, and A.G. Herman Apoptosis in atherosclerosis: beneficial or detrimental? Cardiovasc Res 45 2000 736 746
173. M.R. Bennett Apoptosis of vascular smooth muscle cells in vascular remodeling and atherosclerotic plaque rupture Cardiovasc Res 41 1999 361 368
174. P.J. Best, D. Hasdai, G. Sangiorgi, R.S. Schwartz, D.R. Holmes, and R.D. Simari Apoptosis. Basic concepts and implications in coronary artery disease Arterioscler Thromb Vasc Biol 19 1999 14 22
175. K. Walsh, and J.M. Isner Apoptosis in inflammatory-fibroproliferative disorders of the vessel wall Cardiovasc Res 45 2000 756 765
176. Z. Mallat, and A. Tedgui Apoptosis in the vasculature: mechanisms and functional importance Br J Pharmacol 130 2000 947 962
177. D.R. Green, and J.C. Reed Mitochondria and apoptosis Science 281 1998 1309 1312
178. J.M. Adams, and S. Cory The Bcl-2 protein family: arbiters of cell survival Science 281 1998 1322 1326
179. G. Evan, and T. Littlewood A matter of life and cell death Science 281 1998 1317 1322
180. J.M. Isner, M. Kearney, S. Bortman, and J. Passeri Apoptosis in human atherosclerosis and restenosis Circulation 91 1995 2703 2711
181. M.R. Bennett, G.I. Evan, and S.M. Schwartz Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways Circ Res 77 1995 266 273
182. M.R. Bennett, G.I. Evan, and S.M. Schwartz Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques J Clin Invest 95 1995 2266 2274
183. M.R. Bennett, K. Macdonald, S.W. Chan, J.J. Boyle, and P.L. Weissberg Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques Circ Res 82 1998 704 712
184. P.D. Flynn, C.D. Byrne, T.P. Baglin, P.L. Weissberg, and M.R. Bennett Thrombin generation by apoptotic vascular smooth muscle cells Blood 89 1997 4378 4384
185. Y.J. Geng, T. Azuma, J.X. Tang, J.H. Hartwig, M. Muszynski, and Q. Wu Caspase-3-induced gelsolin fragmentation contributes to actin cytoskeletal collapse, nucleolysis, and apoptosis of vascular smooth muscle cells exposed to proinflammatory cytokines Eur J Cell Biol 77 1998 294 302
186. N.A. Thornberry, and Y. Lazebnik Caspases: enemies within Science 281 1998 1312 1316
187. M.J. Davies, N. Woolf, P. Rowles, and P.D. Richardson Lipid and cellular constituents of unstable human aortic plaques Basic Res Cardiol 89 1994 33 39
188. A. Ashkenazi, and V.M. Dixit Death receptors: signaling and modulation Science 281 1998 1305 1308
189. Prediman K. Shah Mechanisms of plaque vulnerability and rupture J Am Coll Cardiol 41 Supplement 1 2003 S15 S22
190. R.T. Lee, and P. Libby The unstable atheroma Arterioscler Thromb Vasc Biol 17 1997 1859 1867
191. M.M. Kockx, G.R.Y. De Meyer, J. Muhring, W. Jacob, H. Bult, and A.G. Herman Apoptosis and related proteins in different stages of human atherosclerotic plaques Circulation 97 1998 2307 2315
192. M.R. Bennett, G.I. Evan, and S.M. Schwartz Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques J Clin Invest 95 1995 2266 2274
193. M.R. Bennett, and J.J. Boyle Apoptosis of vascular smooth muscle cells in atherosclerosis Atherosclerosis 138 1998 3 9
194. P.T. Kovanen, M. Kaartinen, and T. Paavonen Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction Circulation 92 1995 1084 1088
195. M. Aikawa, and P. Libby Lipid lowering reduces proteolytic and prothrombotic potential in rabbit atheroma Ann NY Acad Sci 902 2000 140 152
196. M. Aikawa, E. Rabkin, S. Sugiyama, S.J. Voglic, Y. Fukumoto, and Y. Furukawa An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro Circulation 103 2001 276 283
197. Y. Fukumoto, P. Libby, E. Rabkin, C.C. Hill, M. Enomoto, and Y. Hirouchi Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits Circulation 103 2001 993 999
198. S. Ameli, A. Hultgardh-Nilsson, B. Cercek, P.K. Shah, J.S. Forrester, and H. Ageland Recombinant apolipoprotein A-1 Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits Circulation 90 1994 1935 1941
199. P.K. Shah, J. Nilsson, S. Kaul, M.C. Fishbein, H. Ageland, and A. Hamsten Effects of recombinant apolipoprotein A-I (Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice Circulation 97 1998 780 785
200. P.K. Shah, J. Yano, O. Reyes, K.Y. Chyu, S. Kaul, and C.L. Bisgaier High-dose recombinant apolipoprotein A-I (Milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein c-deficient mice: potential implications for acute plaque stabilization Circulation 103 2001 3047 3050
201. M. Crisby, G. Nordin-Fredriksson, P.K. Shah, J. Yano, J. Zhu, and J. Nilsson Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization Circulation 103 2001 926 933